Pulmonary hypertension in autoimmune rheumatic diseases: where are we now? (Q34810661)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12209501%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

review article

1 reference

title

Pulmonary hypertension in autoimmune rheumatic diseases: where are we now? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12209501%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference

pulmonary hypertension

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12209501%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

author name string

Magliano M

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12209501%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Hillson J

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12209501%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

publication date

1 August 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12209501%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

published in

Arthritis and Rheumatism

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12209501%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

volume

46

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12209501%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12209501%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

page(s)

1997-2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12209501%20AND%20SRC:MED&resulttype=core&format=json

Increased interleukin-1 and interleukin-6 serum concentrations in severe primary pulmonary hypertension.

12 November 2019

cites work

1 reference

The pulmonary pathologic manifestations of the CREST syndrome

21 January 2018

1 reference

Monoclonal endothelial cell proliferation is present in primary but not secondary pulmonary hypertension

21 January 2018

1 reference

Endothelial dysfunction providing the basis for the treatment of pulmonary hypertension: Giles F. Filley lecture

21 January 2018

1 reference

The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension

21 January 2018

1 reference

Clinical and laboratory features of scleroderma patients with pulmonary hypertension

21 January 2018

1 reference

Pulmonary hypertension in systemic sclerosis: risk factors for progression and consequences for survival

21 January 2018

1 reference

Pulmonary artery pressure variation in patients with connective tissue disease: 24 hour ambulatory pulmonary artery pressure monitoring

21 January 2018

1 reference

Cardiovascular manifestations in systemic lupus erythematosus. Prospective study of 100 patients

21 January 2018

1 reference

Pulmonary hypertension in systemic lupus erythematosus: report of four cases and review of the literature

21 January 2018

1 reference

Five-year follow-up study of the prevalence and progression of pulmonary hypertension in systemic lupus erythematosus

21 January 2018

1 reference

Cardiovascular manifestations of mixed connective tissue disease in adults.

21 January 2018

1 reference

Long-term outcome in mixed connective tissue disease: longitudinal clinical and serologic findings

21 January 2018

1 reference

Mixed connective tissue disease--an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA)

21 January 2018

1 reference

Hypoxic pulmonary vasoconstriction in systemic sclerosis and primary pulmonary hypertension.

21 January 2018

1 reference

Treatment of pulmonary hypertension secondary to connective tissue diseases.

21 January 2018

1 reference

The role of thrombosis in severe pulmonary hypertension

21 January 2018

1 reference

A new era in the treatment of primary pulmonary hypertension

21 January 2018

1 reference

The effect of vasodilator therapy on the clinical outcome of patients with primary pulmonary hypertension

21 January 2018

1 reference

Acute and long-term effects of nifedipine on pulmonary and systemic hemodynamics in patients with pulmonary hypertension associated with diffuse systemic sclerosis, the CREST syndrome and mixed connective tissue disease

21 January 2018

1 reference

Cardiopulmonary hemodynamics in systemic sclerosis and response to nifedipine and captopril

21 January 2018

1 reference

Pharmacotherapy of chronic pulmonary arterial hypertension: value and limitations. Part II: Secondary pulmonary hypertension

21 January 2018

1 reference

Overexpression of prostacyclin synthase inhibits growth of vascular smooth muscle cells

21 January 2018

1 reference

Survival in primary pulmonary hypertension with long-term continuous intravenous prostacyclin

21 January 2018

1 reference

Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension.

21 January 2018

1 reference

Primary Pulmonary Hypertension: Improved Long-Term Effects and Survival With Continuous Intravenous Epoprostenol Infusion

21 January 2018

1 reference

Epoprostenol for treatment of pulmonary hypertension in patients with systemic lupus erythematosus.

21 January 2018

1 reference

Different Hemodynamic Responses between Acute and Chronic Infusion of Iloprost (Prostacyclin-stable Analogue) in Severe Pulmonary Hypertension

21 January 2018

1 reference

Effect of orally active prostacyclin analogue on survival of outpatients with primary pulmonary hypertension.

21 January 2018

1 reference

Increased plasma endothelin-1 in pulmonary hypertension: marker or mediator of disease?

21 January 2018

1 reference

Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study

21 January 2018

1 reference

Pulsed delivery of inhaled nitric oxide to patients with primary pulmonary hypertension: an ambulatory delivery system and initial clinical tests

21 January 2018

1 reference

Sildenafil as a selective pulmonary vasodilator in childhood primary pulmonary hypertension

21 January 2018

1 reference

Haemodynamic and hormonal effects of adrenomedullin in patients with pulmonary hypertension

21 January 2018

1 reference

Lung transplantation for respiratory failure resulting from systemic disease

21 January 2018

1 reference

Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial

21 January 2018

1 reference

Inhaled iloprost to treat severe pulmonary hypertension. An uncontrolled trial. German PPH Study Group

21 January 2018

1 reference

Long-Term Treatment of Primary Pulmonary Hypertension with Aerosolized Iloprost, a Prostacyclin Analogue

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/ART.10442

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12209501%20AND%20SRC:MED&resulttype=core&format=json

release_sjy6idbmvrextc5xqlcdzywiea

12 November 2019

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/sjy6idbmvrextc5xqlcdzywiea

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference